These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
307 related items for PubMed ID: 19760139
1. Liver transplantation for hepatocellular carcinoma: the Hong Kong experience. Ng KK, Lo CM, Chan SC, Chok KS, Cheung TT, Fan ST. J Hepatobiliary Pancreat Sci; 2010 Sep; 17(5):548-54. PubMed ID: 19760139 [Abstract] [Full Text] [Related]
2. Liver transplantation for hepatocellular carcinoma: Korean experience. Lee S, Ahn C, Ha T, Moon D, Choi K, Song G, Chung D, Park G, Yu Y, Choi N, Kim K, Kim K, Hwang S. J Hepatobiliary Pancreat Sci; 2010 Sep; 17(5):539-47. PubMed ID: 19727542 [Abstract] [Full Text] [Related]
3. Living donor liver transplantation for hepatocellular carcinoma. Lee SG, Moon DB. Recent Results Cancer Res; 2013 Sep; 190():165-79. PubMed ID: 22941020 [Abstract] [Full Text] [Related]
4. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis. Liang W, Wu L, Ling X, Schroder PM, Ju W, Wang D, Shang Y, Kong Y, Guo Z, He X. Liver Transpl; 2012 Oct; 18(10):1226-36. PubMed ID: 22685095 [Abstract] [Full Text] [Related]
5. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience. Lee KW, Yi NJ, Suh KS. Transplantation; 2014 Apr 27; 97 Suppl 8():S20-3. PubMed ID: 24849825 [Abstract] [Full Text] [Related]
6. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence. Sandhu L, Sandroussi C, Guba M, Selzner M, Ghanekar A, Cattral MS, McGilvray ID, Levy G, Greig PD, Renner EL, Grant DR. Liver Transpl; 2012 Mar 27; 18(3):315-22. PubMed ID: 22140013 [Abstract] [Full Text] [Related]
7. Living donor liver transplantation for hepatocellular carcinoma: long-term results compared with deceased donor liver transplantation. Di Sandro S, Slim AO, Giacomoni A, Lauterio A, Mangoni I, Aseni P, Pirotta V, Aldumour A, Mihaylov P, De Carlis L. Transplant Proc; 2009 May 27; 41(4):1283-5. PubMed ID: 19460539 [Abstract] [Full Text] [Related]
8. Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma. Ninomiya M, Shirabe K, Facciuto ME, Schwartz ME, Florman SS, Yoshizumi T, Harimoto N, Ikegami T, Uchiyama H, Maehara Y. J Am Coll Surg; 2015 Mar 27; 220(3):297-304.e3. PubMed ID: 25617912 [Abstract] [Full Text] [Related]
9. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation. Park MS, Lee KW, Suh SW, You T, Choi Y, Kim H, Hong G, Yi NJ, Kwon CH, Joh JW, Lee SK, Suh KS. Transplantation; 2014 Jan 15; 97(1):71-7. PubMed ID: 24056623 [Abstract] [Full Text] [Related]
10. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria. Lee EC, Kim SH, Shim JR, Park SJ. Liver Transpl; 2018 Jan 15; 24(1):35-43. PubMed ID: 28885774 [Abstract] [Full Text] [Related]
11. Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation. Bhangui P, Vibert E, Majno P, Salloum C, Andreani P, Zocrato J, Ichai P, Saliba F, Adam R, Castaing D, Azoulay D. Hepatology; 2011 May 15; 53(5):1570-9. PubMed ID: 21520172 [Abstract] [Full Text] [Related]
12. Living donor liver transplantation for hepatocellular carcinoma: the impact of neo-adjuvant treatments on the long term results. Di Sandro S, Giacomoni A, Slim A, Lauterio A, Mangoni I, Mihaylov P, Pirotta V, Aseni P, De Carlis L. Hepatogastroenterology; 2012 May 15; 59(114):505-10. PubMed ID: 22353516 [Abstract] [Full Text] [Related]
13. Does living donation have advantages over deceased donation in liver transplantation? Kaido T, Uemoto S. J Gastroenterol Hepatol; 2010 Oct 15; 25(10):1598-603. PubMed ID: 20880167 [Abstract] [Full Text] [Related]
14. Living-donor liver transplantation for hepatocellular carcinoma. Kaihara S, Kiuchi T, Ueda M, Oike F, Fujimoto Y, Ogawa K, Kozaki K, Tanaka K. Transplantation; 2003 Feb 15; 75(3 Suppl):S37-40. PubMed ID: 12589138 [Abstract] [Full Text] [Related]
15. Liver transplantation for HCC: its role: Eastern and Western perspectives. Hwang S, Lee SG, Belghiti J. J Hepatobiliary Pancreat Sci; 2010 Jul 15; 17(4):443-8. PubMed ID: 19885638 [Abstract] [Full Text] [Related]
16. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma. Yoon YI, Song GW, Lee SG, Hwang S, Kim KH, Kim SH, Kang WH, Cho HD, Jwa EK, Kwon JH, Tak EY, Kirchner VA. J Hepatol; 2018 Jun 15; 68(6):1153-1162. PubMed ID: 29452208 [Abstract] [Full Text] [Related]
17. Expansion of the criteria for living donor liver transplantation for hepatocellular carcinoma. Lee HW, Suh KS. Curr Opin Organ Transplant; 2016 Apr 15; 21(2):231-7. PubMed ID: 26918880 [Abstract] [Full Text] [Related]
18. The role and limitation of living donor liver transplantation for hepatocellular carcinoma. Lo CM, Fan ST, Liu CL, Chan SC, Wong J. Liver Transpl; 2004 Mar 15; 10(3):440-7. PubMed ID: 15004774 [Abstract] [Full Text] [Related]
19. Comparison of the outcomes of patients who underwent deceased-donor or living-donor liver transplantation after successful downstaging therapy. Lei J, Yan L, Wang W. Eur J Gastroenterol Hepatol; 2013 Nov 15; 25(11):1340-6. PubMed ID: 23652915 [Abstract] [Full Text] [Related]
20. Outcome of hepatocellular carcinoma treated by liver transplantation: comparison of living donor and deceased donor transplantation. Li C, Wen TF, Yan LN, Li B, Yang JY, Wang WT, Xu MQ, Wei YG. Hepatobiliary Pancreat Dis Int; 2010 Aug 15; 9(4):366-9. PubMed ID: 20688599 [Abstract] [Full Text] [Related] Page: [Next] [New Search]